T he bacterium Clostridium difficile is the leading cause of healthcare associated diarrhoea in the developed world and thus presents a major financial burden. The main virulence factors of C. difficile are two large toxins, A and B. Over the years there has been some debate over the respective roles and importance of these two toxins. To address this, we recently constructed stable toxin mutants of C. difficile and found that they were virulent if either toxin A or toxin B was functional. This underlined the importance of each toxin and the necessity to consider both when developing countermeasures against Clostridium difficile infection (CDI). In this article we discuss our findings in the context of previous work and outline some of the challenges which face the field as a result.
IntroductionIn recent years Clostridium difficile infection (CDI) has emerged as the leading cause of healthcare associated diarrhoea in the developed world. The endospores of this Gram-positive anaerobe are widely distributed in the environment and their ingestion by hospitalised patients with a disrupted gut microflora, a common consequence of antibiotic treatment, leads to colonisation and subsequent disease.
1-3The clinical symptoms of CDI can range from asymptomatic carriage to a mild selflimiting or severe diarrhoea which may progress to the potentially fatal conditions of pseudomembranous colitis and/ or toxic megacolon. In most developed countries, the incidence of CDI continues to increase, concomitant with the emergence of so-called 'hyper-virulent' strains, responsible for increased severity of CDI and a rise in fatalities. In England and Wales, for example, where the mortality rates attributable to CDI are apparently falling, C. difficile still killed almost 4,000 people in 2009 alone. This upsurge in the incidence of CDI has placed a large financial burden on healthcare systems worldwide.
2
Toxin A and Toxin B in DiseaseTwo main virulence factors, toxin A and toxin B, have been described for C. difficile. The two encoding genes, tcdA and tcdB, respectively, form part of a well defined pathogenicity locus (PaLoc) (Fig. 1). The locus also encompasses three ancillary genes. The tcdR gene encodes an alternative sigma factor (TcdR) responsible for the transcription of tcdA and tcdB.4,5 A second gene tcdC, is suggested to encode an antisigma factor (TcdC) which represses toxin production by directly interacting with TcdR or TcdR-containing RNA polymerase. 6 The third gene, tcdE, codes for a protein (TcdE) which shares similarity to phage holin proteins, and may be involved in toxin secretion. 7 The entire PaLoc element is 19.6 kb in size and, therefore, represents an investment by the organism in terms of its continued maintenance in the genome (Fig. 1).The function of the toxins themselves has been studied extensively and their mode of action is now well understood. Both are cytotoxic and belong to the family of large clostridial toxins, capable of inactivating Rho-GTPases and leading to www.landesbioscience.com
Gut Microbes...